WEDNESDAY, Dec. 4, 2024 (HealthDay News) — American seniors still pay more for health care than their counterparts in most other wealthy countries do, despite coverage by Medicare, a new study finds. They are also more likely to postpone or skip needed care because of cost concerns. “In the U.S.,Continue Reading

TUESDAY, Nov. 26, 2024 (HealthDay News) — The outgoing Biden administration will propose that pricey GLP-1 obesity medications such as semaglutide (Wegovy), and tirzepatide (Zepbound) be covered by Medicare and Medicaid. However, the move would have to be approved by the new Trump administration.  Right now, a law passed byContinue Reading

WEDNESDAY, Nov. 20, 2024 (HealthDay News) — If Congress lets healthcare tax credits established during the pandemic expire, 4 million Americans will become uninsured, a new analysis warns. The tax credits, which have significantly lowered out-of-pocket costs for millions of Americans, are set to expire at the end of 2025.Continue Reading

TUESDAY, Nov. 5, 2024 (HealthDay News) — Poorer folks’ access to blockbuster weight-loss drugs through Medicaid remains limited, a new KFF analysis has found. Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) medications, researchers discovered. Under the Medicaid system, individual states areContinue Reading

MONDAY, Oct. 28, 2024 (HealthDay News) — Hospice care is a compassionate and heartfelt enterprise, involving a medical team dedicated to maintaining a person’s comfort and dignity as they face the final curtain. Now, new research shows hospice is also incredibly cost-effective as a health care service, a new reportContinue Reading

MONDAY, Oct. 14, 2024 (HealthDay News) — A simple tweak in available vial sizes of the breakthrough Alzheimer’s drug Leqembi could save Medicare hundreds of millions of dollars each year, a new analysis claims. About 6% of Leqembi (lecanemab) is discarded because patients are frequently prescribed doses lower than theContinue Reading